Approval for changes in fixation design, lead lengths and enabling bipolar pace/sense capability.  The device, as modified, will be marketed under the trade name easytrak 3 and is indicated for chronic, left ventricular pacing and sensing via the coronary veins, when used in conjunction with a compatible guidant cardiac resynchronization therapy (crt) device.